OVID logo

Ovid Therapeutics (OVID) Free Cash Flow

Annual FCF

-$45.92 M
+$10.73 M+18.94%

December 31, 2023

Summary

Performance

1-Year Change

+18.94%

3-Year Change

+11.65%

5-Year Change

-0.02%

15-Year Change

-45.69%

OVID Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.11%
OVID annual free cash flow is higher than 32.11% of companies in Healthcare sector

High & Low

All-time High

$118.42 M
OVID annual free cash flow is currently -138.78% below its historical high of $118.42 million

3-Year Low

-$56.65 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OVID previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
OVID next annual earnings announcement is scheduled for Mar 7, 2025

OtherOVIDcash flowmetrics:

Annual CFO

-$45.78 M
OVID annual cash flow from operations is -$45.78 million

Annual CFF

$30.54 M
OVID annual cash flow from financing activities is $30.54 million

Annual CFI

-$2.58 M
OVID annual cash flow from investing activities is -$2.58 million

Annual CAPEX

$137.50 K
OVID annual capital expenditures is $137.50 thousand

Quarterly FCF

-$15.00 M
-$598.00 K-4.15%

September 30, 2024

Summary

Performance

3-Month Change

-4.15%

1-Year Change

-25.95%

3-Year Change

-25.95%

5-Year Change

-25.95%

OVID Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

25.98%
OVID quarterly free cash flow is higher than 25.98% of companies in Healthcare sector

High & Low

All-time High

$160.89 M
OVID quarterly free cash flow is currently -109.33% below its historical high of $160.89 million

3-Year Low

-$20.16 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDcash flowmetrics:

Quarterly CFO

-$15.01 M
OVID quarterly cash flow from operations is -$15.01 million

Quarterly CFF

$38.00 K
OVID quarterly cash flow from financing activities is $38.00 thousand

Quarterly CFI

$292.00 K
OVID quarterly cash flow from investing activities is $292.00 thousand

Quarterly CAPEX

-$4000.00
OVID quarterly capital expenditures is -$4000.00

TTM FCF

-$58.02 M
-$4.95 M-9.32%

September 30, 2024

Summary

Performance

3-Month Change

-9.32%

1-Year Change

-26.36%

3-Year Change

-26.36%

5-Year Change

-26.36%

OVID TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.24%
OVID TTM free cash flow is higher than 28.24% of companies in Healthcare sector

High & Low

All-time High

$127.53 M
OVID TTM free cash flow is currently -145.50% below its historical high of $127.53 million

3-Year Low

-$62.63 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OVID previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
OVID next earnings announcement is scheduled for Mar 7, 2025

OtherOVIDcash flowmetrics:

TTM CFO

-$57.86 M
OVID TTM cash flow from operations is -$57.86 million

TTM CFF

$30.66 M
OVID TTM cash flow from financing activities is $30.66 million

TTM CFI

-$15.21 M
OVID TTM cash flow from investing activities is -$15.21 million

TTM CAPEX

$165.50 K
OVID TTM capital expenditures is $165.50 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$45.92 M
OVID annual free cash flow is -$45.92 million

Annual CFO

-$45.78 M
OVID annual cash flow from operations is -$45.78 million

Annual CAPEX

$137.50 K
OVID annual capital expenditures is $137.50 thousand

OVID Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+18.9%-25.9%-26.4%
3 y3 years+11.7%-25.9%-26.4%
5 y5 years-0.0%-25.9%-26.4%

OVID Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-138.8%+18.9%-62.4%+25.6%-149.0%+7.3%
5 y5-year-138.8%+18.9%-109.3%+25.6%-145.5%+7.3%
alltimeall time-138.8%+18.9%-109.3%+25.6%-145.5%+7.3%

Ovid Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$15.00 M(+4.2%)
-$58.02 M(+9.3%)
Jun 2024
-
-$14.40 M(-13.8%)
-$53.08 M(+5.1%)
Mar 2024
-
-$16.70 M(+40.2%)
-$50.50 M(+10.0%)
Dec 2023
-$45.92 M(-18.9%)
-$11.91 M(+18.4%)
-$45.92 M(+6.2%)
Sep 2023
-
-$10.06 M(-14.9%)
-$43.25 M(-5.7%)
Jun 2023
-
-$11.82 M(-2.5%)
-$45.88 M(-5.6%)
Mar 2023
-
-$12.13 M(+31.3%)
-$48.61 M(-14.2%)
Dec 2022
-$56.65 M(-147.8%)
-$9.24 M(-27.2%)
-$56.65 M(-4.9%)
Sep 2022
-
-$12.70 M(-12.7%)
-$59.57 M(+3.1%)
Jun 2022
-
-$14.55 M(-27.8%)
-$57.76 M(-7.8%)
Mar 2022
-
-$20.16 M(+65.8%)
-$62.63 M(-152.9%)
Dec 2021
$118.42 M(-327.8%)
-$12.16 M(+11.7%)
$118.42 M(+2.1%)
Sep 2021
-
-$10.89 M(-43.9%)
$115.98 M(-7.5%)
Jun 2021
-
-$19.42 M(-112.1%)
$125.36 M(-1.7%)
Mar 2021
-
$160.89 M(-1202.0%)
$127.53 M(-345.4%)
Dec 2020
-$51.97 M
-$14.60 M(+866.4%)
-$51.97 M(-4.6%)
Sep 2020
-
-$1.51 M(-91.2%)
-$54.47 M(-12.8%)
Jun 2020
-
-$17.25 M(-7.3%)
-$62.48 M(+9.5%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$18.61 M(+8.9%)
-$57.07 M(+11.2%)
Dec 2019
-$51.33 M(+11.8%)
-$17.10 M(+79.8%)
-$51.33 M(+13.5%)
Sep 2019
-
-$9.51 M(-19.7%)
-$45.22 M(-1.4%)
Jun 2019
-
-$11.85 M(-8.0%)
-$45.88 M(+0.2%)
Mar 2019
-
-$12.88 M(+17.2%)
-$45.80 M(-0.2%)
Dec 2018
-$45.91 M(+45.7%)
-$10.99 M(+8.0%)
-$45.91 M(+4.7%)
Sep 2018
-
-$10.17 M(-13.5%)
-$43.87 M(+1.9%)
Jun 2018
-
-$11.77 M(-9.4%)
-$43.04 M(+15.4%)
Mar 2018
-
-$12.98 M(+45.2%)
-$37.29 M(+18.3%)
Dec 2017
-$31.52 M(+75.2%)
-$8.94 M(-4.3%)
-$31.52 M(+11.1%)
Sep 2017
-
-$9.35 M(+55.3%)
-$28.37 M(+19.6%)
Jun 2017
-
-$6.02 M(-16.5%)
-$23.73 M(+11.3%)
Mar 2017
-
-$7.21 M(+24.3%)
-$21.33 M(+18.5%)
Dec 2016
-$17.99 M(+224.6%)
-$5.80 M(+23.4%)
-$17.99 M(+47.6%)
Sep 2016
-
-$4.70 M(+30.0%)
-$12.19 M(+62.8%)
Jun 2016
-
-$3.62 M(-6.6%)
-$7.49 M(+93.4%)
Mar 2016
-
-$3.87 M
-$3.87 M
Dec 2015
-$5.54 M
-
-

FAQ

  • What is Ovid Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Ovid Therapeutics?
  • What is Ovid Therapeutics annual FCF year-on-year change?
  • What is Ovid Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Ovid Therapeutics?
  • What is Ovid Therapeutics quarterly FCF year-on-year change?
  • What is Ovid Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Ovid Therapeutics?
  • What is Ovid Therapeutics TTM FCF year-on-year change?

What is Ovid Therapeutics annual free cash flow?

The current annual FCF of OVID is -$45.92 M

What is the all time high annual FCF for Ovid Therapeutics?

Ovid Therapeutics all-time high annual free cash flow is $118.42 M

What is Ovid Therapeutics annual FCF year-on-year change?

Over the past year, OVID annual free cash flow has changed by +$10.73 M (+18.94%)

What is Ovid Therapeutics quarterly free cash flow?

The current quarterly FCF of OVID is -$15.00 M

What is the all time high quarterly FCF for Ovid Therapeutics?

Ovid Therapeutics all-time high quarterly free cash flow is $160.89 M

What is Ovid Therapeutics quarterly FCF year-on-year change?

Over the past year, OVID quarterly free cash flow has changed by -$3.09 M (-25.95%)

What is Ovid Therapeutics TTM free cash flow?

The current TTM FCF of OVID is -$58.02 M

What is the all time high TTM FCF for Ovid Therapeutics?

Ovid Therapeutics all-time high TTM free cash flow is $127.53 M

What is Ovid Therapeutics TTM FCF year-on-year change?

Over the past year, OVID TTM free cash flow has changed by -$12.11 M (-26.36%)